Clinicians should assess patients with diabetes for painful DPN (Level B) and those with painful DPN for concurrent mood and sleep disorders (Level B)
ICER Chief Medical Officer David Rind told Reuters that prices have come down a ton in recent years, but high demand means payers are having a lot of problems with affordability of these drugs. ICER estimated the annual net US price for Novos semaglutide at US$6,830, down from US$13,618 in 2022, while Lillys tirzepatide came in at US$7,973 against a list price of about US$13,000
Photo credit To view or add a comment, sign in More Relevant Posts Nimesulide: Unknown Facts, Uses & Side Effects You Must Know
This order felt straightforward and transparent. Nathan Scott Ordered GHK-Cu for research
Any references to skin, follicle, or extracellular-matrix pathways are provided only for research context and do not imply cosmetic or clinical use